Karamanoğlu Mehmetbey University, KEAH
Karaman, Lütfen Seçiniz., 70200, Turkey (Türkiye)
Location status: Recruiting
Location contact
Ahmet Yeşildağ, Prof.Dr
CONTACT
Gökçe Merve Yeşildağ, Dr
CONTACT
NCT Number: NCT07465523
In cases with breast masses, Doppler resistive index values will be calculated for the mass and surrounding healthy tissue and the opposite healthy breast tissue, and their effect on distinguishing between benign and malignant masses will be evaluated.
Interested in participating?
Request Info18 year and older
Female
Observational
Karaman, Lütfen Seçiniz., 70200, Turkey (Türkiye)
Location status: Recruiting
Ahmet Yeşildağ, Prof.Dr
CONTACT
Gökçe Merve Yeşildağ, Dr
CONTACT
The aim of this study is to reveal the role of differences in the resistive index of masses and surrounding tissue in distinguishing between benign and malignant masses using a new approach in the evaluation of breast masses with Doppler ultrasound. The minimum, maximum, and average RI values obtained from the mass and healthy breast tissue will be recorded. The relative RI value difference will be calculated from the RI values of the mass and healthy tissue. Based on the pathology results, the cases will be divided into two groups: benign and malignant. The threshold values of these values in malignant and benign masses will be determined and compared. Additionally, vascular index values in breast masses will be calculated and compared using the relatively new Doppler Microvascular Flow method.
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Time frame: 3-4 months
ROC curve analysis will be applied for the diagnostic performance of relative RI change in benign and malignant lesions.
Contact information is provided by the study sponsor or research team.
Ahmet Yeşildağ, Prof.Dr
CONTACT
Gökçe Merve Arman, Dr.
CONTACT
Ahmet Yesildag
Other
A Novel Approach to the Evaluation of Breast Masses Using Doppler Ultrasonography: Percentage Changes in Resistive Index Between the Mass and Surrounding Normal Parenchyma in Benign-Malignant Differentiation
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT05417516
Breast Neoplasm Female, Cosmetic Outcome
Darlinghurst, New South Wales, Australia
View Trial DetailsNCT03096418
Breast Neoplasm Female
Iowa City, Iowa, United States
View Trial DetailsNCT07387445
Behavior, Breast Cancer
Chicago, Illinois, United States
View Trial DetailsNCT06892275
Adnexal Diseases, Breast Diseases
Washington D.C., District of Columbia, United States
View Trial Details